The Foundation Fighting Blindness has contributed millions of dollars to support vision research at hospitals and universities across Canada.
If you are interested in applying for one of our grant programs, please fill out the applicable forms below. All submissions are reviewed by our expert Scientific Advisory Board.
2019 CALL FOR RESEARCH GRANT APPLICATIONS
The 2019 Grant Competition will support independent investigators and/or research teams with a principal investigator from a Canadian institution who share our goal of developing new therapies that have the potential to transform the lives of people living with blindness and vision loss. NEW: Research related to all blinding eye diseases will be considered.
Duration of Award: Funding is based on a 24-month period.
May 15, 2019: Deadline to submit Letter of Intent
July 19, 2019: Deadline to submit Full Proposal
FFB Research Grant Application General Guidelines PDF
CLINICIAN-SCIENTIST EMERGING LEADER (CESL) AWARD
Clinician-scientist ophthalmologists play an essential role in developing new sight-saving treatments. The FFB’s Clinician-Scientist Emerging Leader (CSEL) Award aims to strengthen the community of clinician-scientists with ophthalmological expertise in Canada by enabling the next generation of ophthalmologists to incorporate research into their careers. In 2018, the FFB is proud to announce a new partnership with Bayer that will allow us to support more emerging leaders, who will fuel our fight against blindness!
July 15, 2019: Deadline to submit Full Proposal
FFB Clinician-Scientist Emerging Leader Award Terms of Reference PDF
***PLEASE DO NOT USE THE BUTTON BELOW TO SUBMIT YOUR APPLICATION*** INSTEAD, USE THIS DROPBOX LINK: https://www.dropbox.com/request/au3ds6LqZSRqrlVTDtdF
Submit your application below
Created and Implemented September 17, 2014
The Foundation Fighting Blindness (FFB) has implemented a patent rights policy for FFB-funded research. The policy can be downloaded here:
Created March 22, 2010
Stem cell research holds promise for finding treatments for various retinal dystrophies. The Foundation Fighting Blindness (FFB) is committed to finding treatments for retinal dystrophies and supports stem cell research as per the Assisted Human Reproduction Act (AHRA), which became law in Canada in March 2004. The Act and its framework ensure the consistent and regulated conduct of research, which balances respect for human life and potential for modern science. The FFB acknowledges the highly sensitive and ethical issues addressed by the Act concerning embryonic stem cell research, and supports efforts to identify alternative sources for therapeutic applications. The FFB respects all points of view on this important topic.
For details about Assisted Human Reproduction in Canada visit www.ahrc-pac.gc.ca.
If you wish not to support embryonic stem cell research, your donation to the FFB can be directed to alternative sources for therapeutic applications, such as gene therapy or to education and public awareness.
Created May 2007
The Foundation Fighting Blindness does not provide funds for indirect costs associated with research. While the Foundation recognizes that these are indeed legitimate expenditures, we believe the funding of such costs is the responsibility of governments and/or research institutions – not donors.
The Foundation is a member in good standing of the Health Charities Coalition of Canada (HCCC). All HCCC members abide by this funding policy. See the HCCC position statement on indirect costs.